PFIZER OFFICIALS SAY THEY HAD NO DUTY TO PREVENT ‘OFF-LABEL’ MARKETING In re Pfizer Inc. S'holder Derivative Litig. | Secondary Sources | Westlaw

PFIZER OFFICIALS SAY THEY HAD NO DUTY TO PREVENT ‘OFF-LABEL’ MARKETING In re Pfizer Inc. S'holder Derivative Litig. | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, PFIZER OFFICIALS SAY THEY HAD NO DUTY TO PREVENT ‘OFF-LABEL’ MARKETING In re Pfizer Inc. S'holder Derivative Litig., Secondary Sources
26 No. 10 Westlaw Journal Pharmaceutical 12
Westlaw Journal Pharmaceutical
*1 November 29, 2010
Shareholder Dispute
Copyright © 2010 Thomson Reuters .

PFIZER OFFICIALS SAY THEY HAD NO DUTY TO PREVENT ‘OFF-LABEL’ MARKETING

In re Pfizer Inc. S'holder Derivative Litig.

Briefs and Other Related Documents
After months of discovery, Pfizer Inc. shareholder plaintiffs have found no evidence that the pharmaceutical giant's officers and directors intentionally sanctioned the marketing of drugs for unapproved “off-label” uses, company officials have told a...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.